The Enterprise Value as of December 2025 (TTM) for Newbury Pharmaceuticals AB (publ) (NEWBRY.ST) is 26.41M

According to Newbury Pharmaceuticals AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 26.41M. This represents a change of -46.08% compared to the average of 48.99M of the last 4 quarters.

Newbury Pharmaceuticals AB (publ) (NEWBRY.ST) Historical Enterprise Value (quarterly & annually)

How has NEWBRY.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Newbury Pharmaceuticals AB (publ) over the last ten years is 90.65M. The current 26.41M Enterprise Value has changed 2.81% with respect to the historical average. Over the past ten years (40 quarters), NEWBRY.ST's Enterprise Value was at its highest in in the November 2021 quarter at 189.82M. The Enterprise Value was at its lowest in in the November 2020 quarter at 0.

Newbury Pharmaceuticals AB (publ) (NEWBRY.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Newbury Pharmaceuticals AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Newbury Pharmaceuticals AB (publ) (NEWBRY.ST) Average Enterprise Value

How has NEWBRY.ST Enterprise Value performed in the past?

The current Enterprise Value of Newbury Pharmaceuticals AB (publ) (NEWBRY.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Newbury Pharmaceuticals AB (publ) (NEWBRY.ST) Enterprise Value vs. Peers

How is NEWBRY.ST’s Enterprise Value compared to its peers?

Newbury Pharmaceuticals AB (publ)’s Enterprise Value is less than Ortivus AB (publ) (55.40M), less than OncoZenge AB (publ) (67.63M), less than Simris Alg AB (publ) (140.02M), greater than Lipigon Pharmaceuticals AB (publ) (-9325792.00), less than AcouSort AB (publ) (40.68M), greater than ExpreS2ion Biotech Holding AB (publ) (8.49M), less than ODI Pharma AB (29.49M), less than ScandiDos AB (publ) (51.81M), less than Scandinavian Real Heart AB (Publ) (40.80M),

Build a custom stock screener for Newbury Pharmaceuticals AB (publ) (NEWBRY.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Newbury Pharmaceuticals AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Newbury Pharmaceuticals AB (publ) (NEWBRY.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Newbury Pharmaceuticals AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.